January 18, 2021
John Papastergiou, arguably Canada's most famous pharmacist, business leader, educator, and pharmacy innovator, has joined us in this episode to tell us about the utilization of pharmacogenomics (PGx) in pharmacy practice, the changing role of pharmacists, and a groundbreaking study that showed the effectiveness of PGx for treating depression in a pharmacy setting.
How can community pharmacists shape the future of pharmacogenetics?
We’ve had a great conversation with John Papastergiou, a pharmacist and pharmacy owner who has not only implemented pharmacogenetics into his store, but has also conducted a study within his own pharmacy that proves the effectiveness of PGx in pharmacies for treating depression.
0.24 - John’s Background
1:52 - His work as a community pharmacist
5:23 - The changing role of pharmacists
8:47 - How services become commonplace
12:07 - John’s experiences with pharmacogenetics
13:36 - Proving that pharmacies can implement pharmacogenetics
21:46 - When PGx is the key: a patient story
25:16 - Reimbursement: the path to becoming the standard of care
28:35 - The importance of a holistic approach to prescribing
30:08 - What are the next steps?
33:00 - Hear more from John
December 9, 2020
Katherine (Katie) Capps, Co-Founder & Executive Director of the GTMRx Institute as well as Founder & President of Health2 Resources, joined us in this episode of Precision Insights to discuss what comprehensive medication management (CMM) is, and how pharmacogenetics can be used in the CMM process.
November 17, 2020
Colleen Keenan, Research Consultant of Advisory Board’s Clinical Innovators Council, joined us in this episode to discuss about how Clinical Innovators Council is making pharmacogenetics a more accessible concept for health system clients, current trends in how health systems are starting to implement and standardize PGx and the challenges around PGx implementation.
October 5, 2020
Sara Rogers, Director of the American Society of Pharmacovigilance (ASP) and Co-Chairman of the Pharmacogenomics Access and Reimbursement Coalition (PARC) joined us in this episode of Precision Insights to discuss the past, present and future of reimbursement for pharmacogenomics.
September 23, 2020
Melissa Badowski, Clinical Associate Professor and Clinical Pharmacist in HIV/Telemedicine for the University of Illinois at Chicago College of Pharmacy, joined us in this episode of Precision Insights to talk about her experience working as part of an inter-professional care team and using telehealth to deliver comprehensive medication management to vulnerable populations.
August 19, 2020
Jared Augenstein, Director of Manatt Health, joined us in this episode of Precision Insights to talk about the reimbursement trends for digital health, the limits of telehealth/virtual care and the opportunities it presents, and differentiating innovations that will improve outcomes, quality, and cost from those that won’t.
July 23, 2020
James Lu, Co-founder and Chief Scientific Officer, Helix, joined us to talk about the current state of genetics use in patient-centered care, the critical elements for successful large-scale genomics initiatives, and a vision to improve care delivery with reusable genetic information for life.
June 15, 2020
Erik Abel, VP Insights, Ursa Health & former Director of Clinical Transformation, Highmark Health, joined us to talk about ways to leverage data & technology to help clinicians make optimized treatment decisions, move towards a truly informed prescribing, and to manage system-level changes in healthcare.
Erik is a subject matter expert in clinical operations, health IT and pharmacotherapeutics.
June 3, 2020
Adrijana Kekic, Pharmacogenomics Pharmacist and Associate Program Director for Outpatient Pharmacy at Mayo Clinic, joined us to talk about the role of pharmacists in delivering personalized care, and the role of technology in enabling PGx implementation at the point of care. You'll also learn about some challenges and exciting developments in personalized medicine.
March 20, 2020
Richard (Curt) Dame, Vice President of Aon Health Solutions Practice, joined us to talk about the deployment of pharmacogenomics into popular health management programs, the successes he has seen through the members' health outcomes, and the future he thinks it has.